A recent study on psoriatic arthritis care revealed that patients and clinicians agree on key aspects of disease management ...
So it can make it hard to diagnose," says Rebecca Haberman, MD, associate director of the NYU Langone's Psoriatic Arthritis ...
LAPIX plans to submit a third IND for LPX-TI641 in the first quarter of 2025 with the dermatology division at the US-FDA.
A study found patients treated with interleukin inhibitors did not experience a difference in the rates of major adverse ...
Explore the gap between patient and clinician perspectives in psoriatic arthritis care. Learn how priorities differ and why ...
Discover how both heat and cold can impact psoriatic arthritis symptoms and learn which is best for your relief.
Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.
I also think that there is, at least in psoriatic arthritis where there's very complex ... or how they manage their disease based on their domain. So, there's lots of sort of treatment decisions ...
Topline data were announced from two phase 3 trials evaluating deucravacitinib, a tyrosine kinase 2 (TYK2) inhibitor, in adults with active psoriatic arthritis (PsA). POETYK PsA-1 (ClinicalTrials.gov ...